tirzepatide presentation gene–disease phenotype–drug response interaction network What to Know Before Starting

While early findings are encouraging, this investigational treatment is still being evaluated, and more evidence is needed to understand its long-term benefits and safety

Agonistas de GLP-1R en esteatohepatitis Los ArGLP-1 han demostrado ser eficaces para lograr prdidas de peso muy significativas (superiores a un 6% los de primera generacin y a un 15% los de segunda generacin) en pacientes con obesidad, tanto con DM2 como sin DM2, por lo que se espera que beneficien a pacientes con esteatohepatitis18,19

All of the participants in the study had obesity or were overweight and had at least one weight-related condition

More specifically, the trial reported that nearly all participants in the highest dose group achieved at least 5% weight loss, which is the clinical threshold used to define a meaningful response

Note: Always follow the specific advice of a healthcare professional or certified diabetes educator for injection technique

Learn More Exercise Program Hybrid exercise training offered by our weight loss clinic provides an effective approach for weight loss, muscle building, and body toning